###begin article-title 0
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human H+ATPase a4 subunit mutations causing renal tubular acidosis reveal a role for interaction with phosphofructokinase-1
###end article-title 0
###begin p 1
###xml 174 191 174 191 <email xmlns:xlink="http://www.w3.org/1999/xlink">fek1000@cam.ac.uk</email>
Address for reprint requests and other correspondence: F. E. Karet, Cambridge Institute for Medical Research, Addenbrooke's Hospital Box 139, Cambridge, CB2 0XY, UK (e-mail: fek1000@cam.ac.uk)
###end p 1
###begin p 2
This document may be redistributed and reused, subject to .
###end p 2
###begin p 3
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 570 571 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 909 910 909 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1210 1211 1210 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1355 1358 1355 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFK</italic>
###xml 1506 1507 1506 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1617 1618 1617 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 196 202 <span type="species:ncbi:9606">humans</span>
###xml 517 522 <span type="species:ncbi:4932">yeast</span>
###xml 866 871 <span type="species:ncbi:4932">yeast</span>
The vacuolar-type ATPase (H+ATPase) is a ubiquitously expressed multisubunit pump whose regulation is poorly understood. Its membrane-integral a-subunit is involved in proton translocation and in humans has four forms, a1-a4. This study investigated two naturally occurring point mutations in a4's COOH terminus that cause recessive distal renal tubular acidosis (dRTA), R807Q and G820R. Both lie within a domain that binds the glycolytic enzyme phosphofructokinase-1 (PFK-1). We recreated these disease mutations in yeast to investigate effects on protein expression, H+ATPase assembly, targeting and activity, and performed in vitro PFK-1 binding and activity studies of mammalian proteins. Mammalian studies revealed complete loss of binding between the COOH terminus of a4 containing the G-to-R mutant and PFK-1, without affecting PFK-1's catalytic activity. In yeast expression studies, protein levels, H+ATPase assembly, and targeting of this mutant were all preserved. However, severe (78%) loss of proton transport but less decrease in ATPase activity (36%) were observed in mutant vacuoles, suggesting a requirement for the a-subunit/PFK-1 binding to couple these two functions. This role for PFK in H+ATPase function was supported by similar functional losses and uncoupling ratio between the two proton pump domains observed in vacuoles from a PFK-null strain, which was also unable to grow at alkaline pH. In contrast, the R-to-Q mutation dramatically reduced a-subunit production, abolishing H+ATPase function completely. Thus in the context of dRTA, stability and function of the metabolon composed of H+ATPase and glycolytic components can be compromised by either loss of required PFK-1 binding (G820R) or loss of pump protein (R807Q).
###end p 3
###begin p 4
###xml 140 153 140 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 4
###begin p 5
###xml 0 22 0 22 <sc xmlns:xlink="http://www.w3.org/1999/xlink">transporting epithelia</sc>
###xml 150 151 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 270 272 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 630 631 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 571 579 <span type="species:ncbi:405018">cardinal</span>
transporting epithelia of the distal nephron contain a group of cells known as alpha-intercalated cells (alpha-ICs), which express a high density of H+ATPases on their apical plasma membranes. These cells are responsible for urine acidification in response to acidosis (14). Proper alpha-IC function is important not only for the maintenance of bodily acid-base homeostasis, but also for maintaining calcium solubility in urine and its stability in bone. Functional failure of alpha-ICs results in metabolic acidosis, which together with nephrocalcinosis and rickets are cardinal features of distal renal tubular acidosis (dRTA) (1).
###end p 5
###begin p 6
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r55">55</xref>
In addition to their vital function in the kidney, H+ATPases pump protons across the plasma membranes of other cell types, such as osteoclasts and cells that line the epididymis and vas deferens, as well as being essential for acidification of many intracellular compartments in eukaryotic cells (5, 55).
###end p 6
###begin p 7
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r55">55</xref>
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 241 242 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r49">49</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r55">55</xref>
###xml 444 445 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 451 452 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 486 487 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 638 639 638 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 653 654 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 746 747 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r55">55</xref>
###xml 877 878 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 884 885 884 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 1003 1004 1003 1004 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1009 1010 1009 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 615 620 <span type="species:ncbi:4932">yeast</span>
H+ATPases from fungi, plants, and animals are structurally very similar, consisting of two major functional domains known as V1 and V0 (55). The V1 domain, comprised of eight different subunits (A-H), is responsible for ATP hydrolysis. The V0 domain contains at least five different subunits (a, c, c'', d, and e) and transports protons across the membrane (49, 55). This proton pumping requires both structural and functional coupling of the V1 and V0 domains. Assembly of the V1 and V0 subcomplexes into the holoenzyme is completed in the ER, the pump then being targeted to the required destination (15, 40). In yeast cells lacking a V1 domain, the V0 domain can still be assembled and targeted onto the vacuolar membrane. Conversely, if the V0 domain is absent, the V1 domain is assembled, but cannot be attached onto the membrane (reviewed in Ref. 55). In addition, free V1 and V0 domains lack MgATP hydrolytic and proton transport activity, respectively, indicating a requirement for coupling of V1 to V0 for normal pump function.
###end p 7
###begin p 8
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r59">59</xref>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r55">55</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast studies demonstrated that disruption of genes encoding any one subunit of the H+ATPase leads to a defect of vacuolar acidification, due to failure of either pump assembly or functional coupling between V1 and V0 domains (19, 41, 59). These deletion strains exhibit a conditional growth phenotype (Vma-) whereby they can only grow at acidic pH, and not at neutral or higher pH, nor in the presence of high levels of extracellular divalent cations, nor in media containing only nonfermentable sources of carbon (16, 41, 55).
###end p 8
###begin p 9
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 44 45 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r47">47</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 216 221 <span type="species:ncbi:4932">yeast</span>
###xml 338 343 <span type="species:ncbi:4932">yeast</span>
###xml 600 605 <span type="species:ncbi:4932">yeast</span>
The H+ATPase a-subunit, a component of the V0 domain, comprises a large NH2-terminal hydrophilic half, several transmembrane helices, and a small soluble COOH-terminal tail (20, 30, 47). Unlike all other subunits in yeast, two different a-subunit paralogs have been identified, Vph1p and Stv1p (38, 39). Vph1p resides in the vacuole, and yeast studies suggest that its COOH-terminal tail is critical not only for proton pumping, but also for stability of Vph1p, and assembly, targeting, and activity of the pump (24, 29, 44). In contrast, Stv1p resides in the Golgi. Both paralogs must be absent for yeast to exhibit the conditional (Vma-) phenotype (39).
###end p 9
###begin p 10
###xml 206 208 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 210 212 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r51">51</xref>
###xml 213 215 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r53">53</xref>
###xml 427 429 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 431 433 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 435 437 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 439 441 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r52">52</xref>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 18 24 <span type="species:ncbi:9606">humans</span>
In both mouse and humans, four different a-subunit paralogs (a1-a4) exist. Of these, a4 is expressed predominantly in the kidney, being located apically in alpha-ICs and subapically in the proximal tubule (45, 51-53). Defects in the genes encoding a4, the osteoclast-enriched a3, and endosomal a2 subunits are associated with recessively inherited dRTA (rdRTA), infantile malignant osteopetrosis, and cutis laxa, respectively (12, 27, 28, 52), underscoring the functional importance of this subunit in kidney, bone, and skin.
###end p 10
###begin p 11
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r52">52</xref>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r52">52</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r56">56</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r58">58</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r57">57</xref>
The gene encoding a4 was identified as the second causative gene for rdRTA (52), the first encoding B1, another renal H+ATPase subunit (22). A wide variety of homozygous mutations have been reported, most of which are predicted to disrupt the encoded protein (52, 56, 58). Only a few missense mutations have been described, two of which, R807Q and G820R, affect residues in the COOH terminus within a domain of the a-subunit that we previously reported is responsible for binding to PFK-1 (57).
###end p 11
###begin p 12
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 191 196 <span type="species:ncbi:4932">yeast</span>
To date, no laboratory has been able to achieve stable epithelial cell expression of the mammalian a-subunit; so to ascertain disease-causing mechanisms in these forms of rdRTA, we turned to yeast to investigate their effects on protein expression, H+ATPase assembly/targeting, and enzyme activity, together with the relationship between the a-subunit/PFK-1 interaction and H+ATPase function.
###end p 12
###begin title 13
MATERIALS AND METHODS
###end title 13
###begin title 14
Strain and plasmid construction.
###end title 14
###begin p 15
###xml 9 18 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stv1&#916;</italic>
###xml 19 28 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vph1&#916;</italic>
###xml 55 68 47 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 70 72 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 148 152 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VPH1</italic>
###xml 156 160 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STV1</italic>
###xml 55 68 <span type="species:ncbi:4932">S. cerevisiae</span>
KEBY9, a stv1Delta/vph1Delta double deletion strain of S. cerevisiae (23), was used for transformation of plasmid constructs. The coding regions of VPH1 or STV1 and their 5' and 3' UTRs amplified in-house by PCR were separately cloned into the low-copy (CEN) plasmid pRS316 to create constructs pKGB1 and pKEB4, respectively. Site-directed mutagenesis using the QuikChange Mutagenesis Kit (Stratagene) was performed using pKGB1 as template; base substitutions were separately introduced into codon 799 (CGT-->CAA) or codon 812 (GGT-->CGT), resulting in the single amino acid changes R-->Q (pKGB1-R799Q) or G-->R (pKGB1-G812R), respectively. All constructs were sequence-verified before use.
###end p 15
###begin title 16
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast complementation assay.
###end title 16
###begin p 17
###xml 180 181 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 316 317 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
KEBY9 cells were transformed with either pKGB1-R799Q, pKGB1-G812R, pKGB1, or empty vector as control, followed by selection on SD-U medium. Colonies were resuspended in 30 mul of H2O, which was then serially diluted and 5 mul of each dilution was pipetted onto YPD buffered to either pH 5, 7.5, or 7 with 100 mM CaCl2. Cell growth was scored following incubation at 25, 30, or 37degreesC for 3 days. Each assay was performed twice.
###end p 17
###begin p 18
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFK</italic>
###xml 49 81 49 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;pfk1:: LEU2.&#916;pfk2::URA2</italic>
###xml 237 238 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 258 260 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
For experiments using the PFK-null yeast strain (Deltapfk1:: LEU2.Deltapfk2::URA2, gift of E. Boles, Frankfurt), 2% ethanol + 0.2% glucose replaced 2% glucose in the media, to provide a suitable carbon source while avoiding spontaneous H+ATPase disassembly (21).
###end p 18
###begin title 19
Whole cell lysates and isolation of vacuolar membrane vesicles.
###end title 19
###begin p 20
###xml 28 31 28 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast cells were grown to OD600 of 0.8 in SD-U medium at 30degreesC. Whole cell lysates were prepared using YeastBuster Protein Extraction Reagent (Novagen).
###end p 20
###begin p 21
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r48">48</xref>
###xml 137 140 131 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 332 333 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 335 336 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 356 357 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Vacuolar membrane vesicles were isolated essentially as described (48) with minor modifications: after growth in SD-U at 30degreesC to OD600 of 1-2, cells resuspended in 50 mM Tris.HCl, pH 9.5, containing 10 mM DTT were incubated at 30degreesC for 30 min. Cells were spheroplasted at 30degreesC for 90 min in 1.2 M sorbitol, 50 mM K3PO4 (pH 7.4), 5 mM MgCl2, 1% glucose, and 3.6 mg/ml zymolyase 100T. Spheroplasts were lyzed and vacuoles were purified by flotation on a discontinuous Ficoll 400 gradient. Purified vacuoles were resuspended in TE, pH 7.4, containing 1 mM PMSF and 1 mug/ml leupeptin.
###end p 21
###begin p 22
###xml 154 155 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 147 152 <span type="species:ncbi:4932">yeast</span>
Whole cell lysate and vacuole samples were analyzed by Western blot using mouse monoclonal antibodies 10D7 (alpha-Vph1p) and 8B1 (alpha-Vma1p, the yeast V1 domain's A subunit; Molecular Probes). Data were quantified densitometrically using ChemiImager V5.5 software.
###end p 22
###begin title 23
Immunofluorescence microscopy.
###end title 23
###begin p 24
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r48">48</xref>
###xml 235 237 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 42 47 <span type="species:ncbi:4932">yeast</span>
###xml 130 134 <span type="species:ncbi:9925">goat</span>
###xml 195 201 <span type="species:ncbi:9986">rabbit</span>
###xml 332 336 <span type="species:ncbi:9925">goat</span>
###xml 343 349 <span type="species:ncbi:9986">rabbit</span>
Spheroplasting, fixation, and mounting of yeast cells were performed as described (48). Following blocking for 1 h with 1% normal goat serum in PBS/BSA (5 mg/ml), cells were incubated first with rabbit polyclonal alpha-Vph1p antibody (18) (gift of T. Stevens to K. Bowers) at room temperature (RT) for 2.5 h, then biotin-conjugated goat alpha-rabbit (Jackson Immuno Research) secondary for 1 h, followed by 1 h with streptavidin-conjugated fluorescein, DTAF (Jackson ImmunoResearch). Slides were mounted in Vectashield Mounting Medium with DAPI (Vector Labs). All images were collected with a Zeiss Axiovert 200M microscope.
###end p 24
###begin title 25
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
H+ATPase functional assays.
###end title 25
###begin p 26
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 477 478 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
Bafilomycin-sensitive ATPase activity of yeast vacuoles was measured as described (13). Three micrograms of vacuoles were added into 1 ml of assay mixture [50 mM KCl, 50 mM Tris, pH 8.0, 2 mM MgCl2, 0.2 mM NADH, 1 mM phosphoenolpyruvate, 2 mM MgATP (pH 7.4), 10-11 U/ml lactate dehydrogenase, and 12-13 U/ml of pyruvate kinase (Sigma)] at 25degreesC. The corresponding decrease in absorbance of NADH at 340 nm was monitored for 4 min, with and without the addition of 0.3 muM H+ATPase inhibitor bafilomycin A using a UV-1601 spectrophotometer.
###end p 26
###begin p 27
###xml 316 318 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 43 48 <span type="species:ncbi:4932">yeast</span>
ATP-dependent proton transport activity of yeast vacuole samples was measured using fluorescence quenching of acridine orange (Sigma) by 3-4 mug vacuoles in buffer [20 mM Mops/Tris, pH 7, 150 mM KCl, 4 muM acridine orange, 1 mM Mg/ATP, with and without bafilomycin A (0.3 muM)] and corrected for mass, as described (43).
###end p 27
###begin p 28
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
These H+ATPase functional properties were measured in triplicate in each of two separate vacuole preparations. For each type of assay, comparison of wild-type (WT) with mutant activities was made by taking WT levels as 100%.
###end p 28
###begin title 29
Peptide synthesis.
###end title 29
###begin p 30
###xml 95 101 95 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 77 82 <span type="species:ncbi:9606">human</span>
Peptides corresponding to the coding sequences of the last 45 residues of WT human a4 (a4C-WT; Fig. 1) or a4C containing G820R (a4C-GR) with acetylated NH2 termini were synthesized and HPLC-purified by CovalAb UK (Cambridge, UK).
###end p 30
###begin title 31
Expression and purification of PFK-1.
###end title 31
###begin p 32
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFK</italic>
###xml 152 168 152 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 733 739 727 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 62 68 <span type="species:ncbi:9986">rabbit</span>
###xml 152 168 <span type="species:ncbi:562">Escherichia coli</span>
###xml 622 626 <span type="species:ncbi:9925">goat</span>
PCR-amplified and sequence-verified cDNA encoding full-length rabbit muscle-type PFK-1 was cloned into pET5a plasmid and expressed in the PFK-deficient Escherichia coli strain DF1020 (7), which was modified by lysogenization with lambda (DE3) prophage (Novagen) at 30degreesC for 6 h. Cells were lysed by sonication and PFK-1 was purified first through a Cibacron blue 3GA-agarose column (Sigma) and then by ammonium sulfate precipitation and finally by an HiTrap Q HP anion exchange column (Amersham Biosciences). Purity, specificity, and activity of the recombinant PFK-1 were analyzed by SDS-PAGE, Western blot using a goat polyclonal anti-PFK-1 antibody (Chemicon Europe), and enzyme activity assays, respectively (Supplementary Fig. 1), before use (the online version of this article contains supplemental data).
###end p 32
###begin title 33
Surface plasmon resonance analysis.
###end title 33
###begin p 34
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 322 328 <span type="species:ncbi:9986">rabbit</span>
Binding affinity analysis was performed on a BIAcore 2000 biosensor system (Pharmacia Biosensor AB) using surface plasmon resonance (SPR) measurements. A carboxymethylated CM5 sensor chip was activated with a 1:1 mixture of 0.4 M N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide and 0.1 M N-hydroxysuccinimide. Recombinant rabbit muscle-type PFK-1 (60 mug/ml in 10 mM NaOAc, pH 5) was then immobilized on the sensor chip by amine-coupling according to the manufacturer's instructions. Unreacted sites were blocked with 1 M ethanolamine/HCl (pH 8). Control flow cells were activated and blocked in the absence of PFK-1. Flow cells were routinely equilibrated with running buffer (PBS, 0.005% surfactant P20). Each synthetic a4C peptide was diluted in this buffer and allowed to interact with the sensor surface by a 180-s injection. Five to one hundred seventy five micromolar each a4C peptide was injected, each at a flow rate of 10 mul/min at 25degreesC. Data from duplicate assays were modelled for binding equilibria using Origin (OriginLab software).
###end p 34
###begin title 35
Circular dichroism spectroscopy.
###end title 35
###begin p 36
###xml 619 620 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
Secondary structures of a4C peptides were analyzed with far-UV circular dichroism (CD) spectroscopy. Spectra were measured using a Jasco J-810 spectropolarimeter at 25degreesC. Each peptide was dissolved in 20 mM phosphate buffer (pH 7) to a final concentration of 25 or 50 muM before being transferred into a measuring cuvette (cell length 0.2 mm). Wavelength scans were collected in 0.2-nm decrements from 260 to 180 nm with a 1-nm bandwidth and a 2-s time constant at 50 nm/min. Ten scanning spectra were averaged for each sample. Estimates of secondary structural components were obtained using CDNN (version 2.1) (3).
###end p 36
###begin title 37
PFK-1 activity assay.
###end title 37
###begin p 38
###xml 189 191 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 193 195 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 257 258 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 420 426 <span type="species:ncbi:9986">rabbit</span>
PFK-1 activity measurements were conducted by coupling the reaction catalyzed by PFK-1 to oxidation of NADH and monitoring the corresponding decrease in absorbance at 340 nm at 25degreesC (10, 31). Reaction mixtures contained 50 mM Tris.HCl, pH 8, 5 mM MgCl2, 1 mM DTT, 0.2 mM NADH, 40 mug/ml aldolase, 2 mul/ml triosephosphate isomerase + glycerophosphate dehydrogenase readymade mixture (Roche), 10 mug/ml recombinant rabbit muscle-type PFK-1, 1 mM ATP, and 0.0275 to 0.305 mM fructose-6-phosphate (F6P). To investigate the potential effects of a4C on PFK-1 activity, each a4C peptide was preincubated with PFK-1 for 2 h at RT before inclusion in the reaction mixture. Each peptide was assayed on three different occasions. Kinetic data were analyzed using Origin.
###end p 38
###begin title 39
Coimmunoprecipitation.
###end title 39
###begin p 40
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VPH1</italic>
###xml 314 315 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 495 503 484 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">buffer A</italic>
###xml 527 528 516 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 548 556 537 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">buffer A</italic>
###xml 604 612 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">buffer A</italic>
###xml 926 928 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 881 886 <span type="species:ncbi:4932">yeast</span>
Thirty-five micrograms of the vacuoles isolated as above from KEBY9 cells transformed with VPH1-containing plasmid were resuspended in binding buffer (TBS, 1% NP40, 10% glycerol) and incubated overnight at 4degreesC with 20 mul of 13D-11 monoclonal antibody (Molecular Probes) against Vma2p, the B subunit of the V1 domain. Antibody was omitted in parallel control experiments. After 1-h incubation with alpha-mouse IgG-agarose beads (Sigma), the immunoprecipitates were washed three times with buffer A (TBS, 1% NP40, 5 mM NaN3); three times with buffer A plus 500 mM NaCl; and finally three times with buffer A. Bound proteins were eluted from beads in SDS sample buffer (0.18 M Tris.HCl, pH 6.8, 5.14% SDS, 18% glycerol, 0.3 M DTT, 0.006% bromophenol blue) at 95degreesC for 5 min and supernatants were subjected to SDS-PAGE. Western blot was performed with an antibody against yeast Pfk (gift of J. Heinisch, Osnabrueck) (17).
###end p 40
###begin title 41
RESULTS
###end title 41
###begin p 42
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP6V0A4</italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r52">52</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r56">56</xref>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 158 165 <span type="species:ncbi:9606">patient</span>
###xml 188 195 <span type="species:ncbi:9606">patient</span>
###xml 446 453 <span type="species:ncbi:9606">patient</span>
###xml 544 551 <span type="species:ncbi:9606">patient</span>
The ATP6V0A4 mutations investigated in this study were previously reported as homozygous alterations in two different patients diagnosed with rdRTA: G820R in patient 5-1 (52) and R807Q in patient 70-1 (56) (Supplementary Table 1). They presented at 11 and 2 mo of age, respectively, with normal anion gap metabolic acidosis and inappropriately alkaline urine, fulfilling diagnostic criteria. Following the original report, audiometry at age 9 in patient 5-1 revealed no evidence of hearing loss, whereas by this age, severe loss was present in patient 70-1 who is now profoundly deaf.
###end p 42
###begin p 43
###xml 37 46 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vph1&#916;</italic>
###xml 47 56 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stv1&#916;</italic>
###xml 155 157 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 239 240 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 378 379 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 372 379 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 590 596 582 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 684 685 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 678 685 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 904 905 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 898 905 890 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1239 1240 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1233 1240 1221 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 73 78 <span type="species:ncbi:4932">yeast</span>
###xml 188 193 <span type="species:ncbi:4932">yeast</span>
###xml 334 339 <span type="species:ncbi:4932">yeast</span>
###xml 423 428 <span type="species:ncbi:4932">yeast</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 819 824 <span type="species:ncbi:4932">yeast</span>
We wished to express human a4 in the vph1Delta/stv1Delta double deletion yeast strain KEBY9, in which expression of either Vph1p or Stv1p restores growth (39). For initial validation of a yeast model, we coimmunoprecipitated the vacuolar H+ATPase and Pfk from KEBY9 reconstituted with Vph1p, to confirm that the two are associated in yeast as well as in mammalian tissue (Fig. 1A), observing a band of the correct size for yeast Pfk in the + lane only. Unfortunately, WT human a4 constructs in two different vectors could not complement KEBY9 growth under several conditions (Supplementary Fig. 2). Instead, we took advantage of the high homology of this region across species (Fig. 1B) and recreated the mutations R799Q and G812R in conserved residues of Vph1p for these studies. Compared with WT Vph1p transformants, yeast cells carrying the R799Q mutant could not rescue the deletion phenotype (Fig. 2A). However, cells containing the G812R mutant protein showed no obvious difference in growth compared with WT under all conditions tested, indicating complementation. Using whole cell lysates of each sample, Western blot using alpha-Vph1p antibody demonstrated that the level of G812R mutant protein was comparable to WT Vph1p (Fig. 2B). In contrast, an 86% reduction of R799Q mutant protein was observed, in keeping with the complementation results.
###end p 43
###begin p 44
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 194 195 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 203 204 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 248 249 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 242 249 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 427 428 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 452 453 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 459 460 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
To test the effect of the mutations on assembly and targeting of the H+ATPase, isolated vacuoles were first analyzed by Western blot using alpha-Vph1p and alpha-Vma1p antibodies, to identify a V0 and a V1 component, respectively. As shown in Fig. 2C, G812R mutant vacuoles showed levels of both Vph1p and Vma1p comparable to WT cells, suggesting that this mutation does not impair assembly or vacuolar targeting of the intact H+ATPase, for which both V1 and V0 domains must be present. The reduced level of Vph1p observed in R799Q mutant vacuoles was similar to those found in the whole cell preparation but was still accompanied by Vma1p, suggesting that the small amount of mutant R799Q protein produced is capable of being assembled and targeted onto vacuolar membranes.
###end p 44
###begin p 45
###xml 65 71 65 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;C</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 340 347 340 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>G</italic></xref>
###xml 449 455 449 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 463 464 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 498 505 498 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
Concomitant immunocytochemistry showed that similar to WT Vph1p (Fig. 3, A-C), the G812R mutant was expressed and localized at the vacuolar membrane (E and F) in almost every cell (D), further confirming normal expression and targeting of these mutant pumps. Predictably, the majority of R799Q mutant cells showed almost no Vph1p staining (Fig. 3G). However, a small population of cells did show some vacuolar membrane localization of mutant Vph1p (Fig. 3, H and I), in good agreement with data in Fig. 2C.
###end p 45
###begin p 46
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 321 327 321 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 540 541 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 553 554 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 671 672 667 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 695 696 691 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 943 945 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 751 756 <span type="species:ncbi:4932">yeast</span>
###xml 1031 1036 <span type="species:ncbi:4932">yeast</span>
We next investigated both ATPase and proton translocation activity of R799Q or G812R mutant pumps. As expected from the low protein levels, the R799Q mutation led to almost complete loss of both bafilomycin-sensitive ATPase and proton transport activity, indicating a lethal effect of this mutation on H+ATPase function (Fig. 4). In marked contrast, the G812R mutant lost 36 +/- 5% of WT levels of bafilomycin-sensitive ATPase activity, but a much greater fraction of proton transport (78 +/- 4%). The significant difference between these (P = 0.023 by t-test) is indicative that this mutation leads to loss of the required functional coupling between proton transport (V0) and ATP hydrolysis (V1), but preserves enough proton translocation to permit yeast cell growth at alkaline pH. Interestingly, the severe loss of proton translocation observed for this mutant is similar to that reported in an earlier study of a3 and a4 subunit mutants (44) but there, ATPase activity was also severely impaired. The authors used a different yeast strain, in which Vph1p but not Stv1p was deleted, and this difference is one feature that may account for differing results.
###end p 46
###begin p 47
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 397 403 397 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 357 363 <span type="species:ncbi:9986">rabbit</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
In the face of preserved expression, assembly, and targeting of this mutant H+ATPase, we hypothesized that the functional uncoupling and severe reduction in pump activity engendered by the G to R substitution might result from disruption of the a4/PFK-1 interaction. To test this, we expressed, purified, and confirmed the enzymatic activity of full-length rabbit muscle-type PFK-1 (Supplementary Fig. 1), synthesized WT and mutant peptides corresponding to the last 45 amino acids of human a4 (a4C-WT and a4C-GR), and then performed SPR analysis using the BIAcore system.
###end p 47
###begin p 48
###xml 117 125 117 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Figure 5</xref>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 228 234 228 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 493 494 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 494 495 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 384 390 <span type="species:ncbi:9986">rabbit</span>
BIAcore measurements are expressed in resonance units (RU) proportional to the concentration of immobilized protein. Figure 5, A and C, displays sensorgrams of a4C-WT (top) or a4C-GR mutant peptide (bottom) binding to PFK-1 and Fig. 5, B and D, shows the corresponding binding curves. The Kd value for a4C-WT/PFK-1 interaction was 29.4 +/- 6.2 muM. A similar value was obtained using rabbit liver-type PFK-1 (Sigma) in place of the recombinant muscle-type PFK-1 (data not shown). However, the Kd value for a4C-GR/PFK-1 interaction could not be generated due to extremely low affinity, indicating severe disruption of binding.
###end p 48
###begin p 49
###xml 276 284 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Figure 6</xref>
###xml 589 596 567 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
We then asked whether this disruption might be explained by secondary structural alteration in a4C-GR. The CD spectra of both WT and mutant a4C peptides exhibit the two large negative bands approximately208 and 222 nm suggestive of mainly alpha-helical structure in solution. Figure 6 shows data for 50 muM peptides; data for 25 muM analysis were not different. A rightward shift was evident in the a4C-GR mutant spectrum, and spectral analysis using the program CDNN suggested an increase in random coils of almost 50%, with a concomitantly decreased alpha-helical content in the mutant (Table 1), indicating some loss of regular structure.
###end p 49
###begin p 50
###xml 404 410 403 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 596 602 594 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7</xref>
###xml 607 614 605 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 639 640 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 640 641 638 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 741 742 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
To exclude a direct effect of the a4C-GR peptide on enzyme activity of PFK-1, we measured the comparative activity of PFK-1 in phosphorylating F6P with and without inclusion of WT or mutant a4C. a4C-WT peptides ranging between 3 and 50 muM were initially preincubated with PFK-1 and then incorporated into a reaction mixture containing an excess of F6P; similar activity levels were found (Supplementary Fig. 3). Thereafter, experiments employing 6 muM a4C with varying amounts of F6P generated saturation curves and kinetic parameters that best fitted the first-order Michaelis-Menten equation (Fig. 7 and Table 2). Specific activity and Km values for a4C peptide-bound PFK-1 were not significantly different from that of free PFK-1 alone (P > 0.45), confirming that neither WT nor mutant a4C peptide affected PFK-1's catalytic ability.
###end p 50
###begin p 51
###xml 77 90 77 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces</italic>
###xml 201 204 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFK</italic>
###xml 233 242 226 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfk1/Pfk2</italic>
###xml 398 399 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 426 427 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 420 427 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 653 654 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 647 654 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 846 859 837 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 1059 1060 1048 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1066 1067 1055 1056 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 119 124 <span type="species:ncbi:4932">Yeast</span>
###xml 451 456 <span type="species:ncbi:4932">yeast</span>
###xml 846 859 <span type="species:ncbi:4932">S. cerevisiae</span>
Finally, to confirm the role of PFK in proton pump regulation, we employed a Saccharomyces strain lacking this enzyme. Yeast Pfk is a hetero-octamer containing two subunits, alpha and beta, encoded by PFK-1 and -2, respectively. The Pfk1/Pfk2 null strain requires a nonfermentable carbon source such as ethanol for growth. In the presence of both ethanol and a small amount of glucose (to prevent H+ATPase disassembly), Fig. 8A demonstrates that like yeast lacking both proton pump a-subunits, the absence of Pfk imposes a pH-conditional growth phenotype whereby growth cannot proceed at raised pH, indicating defective vacuolar function. Second (Fig. 8B), vacuoles isolated from this strain behaved similarly to those from the G812R mutant strain, demonstrating similar loss of bafilomycin-sensitive ATPase activity (39 +/- 1%) compared with WT S. cerevisiae, with again a much more severe accompanying proton translocation loss (83 +/- 2%), confirming Pfk's role as a cofactor for proton pump function and necessary mediator of functional coupling between V1 and V0 domains.
###end p 51
###begin title 52
DISCUSSION
###end title 52
###begin p 53
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r57">57</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 128 133 <span type="species:ncbi:9606">human</span>
H+ATPases form complexes with glycolytic enzymes; we previously identified an interaction between the COOH-terminal tail of the human a-subunit and PFK-1 (57), and the E subunit has been found to interact with aldolase (35). Since the integrity of proton pump function is dependent on the presence of glucose (21), these observations provided a potential regulatory mechanism for H+ATPase in higher eukaryotes, and highlight the functional importance of the a-subunit's COOH terminus. By seeking insight into mechanisms of disease caused by the two known disease-causing mutations (R807Q and G820R) in the COOH terminus of a4, we here established an important role for PFK-1 in the proton pump complex.
###end p 53
###begin p 54
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 153 158 <span type="species:ncbi:4932">yeast</span>
Both R807 and G820 are highly conserved across species, and both lie within a region that is similarly highly conserved. While the R799Q mutation in the yeast model resulted in loss of protein and therefore function, which is commonly found in recessive disease, the mechanism underlying rdRTA associated with the G820R substitution is the more complex, affecting neither stability of the encoded protein nor assembly and targeting efficiency of the H+ATPase. Instead, the observed significant reductions in both ATP hydrolysis and more importantly, proton translocation, were associated with a dramatically lowered binding affinity between the mutant a-subunit tail and PFK-1, such that the interaction was too weak to generate kinetic data. This disruption of binding could have resulted from the change of the residue's charge and/or from the change in secondary structure of the a4C region as suggested by CD spectroscopy analysis.
###end p 54
###begin p 55
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r50">50</xref>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 472 473 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 659 660 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Coupling of proton transport and ATP hydrolysis (subserved by V0 and V1 domains, respectively) is essential for normal overall function of H+ATPases. Intrinsic subunits from both domains (namely A, C, H, a, and d) have been reported to play a role in this functional coupling (4, 6, 42, 50). Although changes in coupling efficiency are recognized as an important mechanism for regulating H+ATPase activity, being affected by nonprotein factors such as ATP, trypsin, or NaN3, the normal intracellular signals controlling coupling remain unclear (11). Our finding of a role for PFK, a known pump-associated protein, provides new insight into the regulation of H+ATPase activity.
###end p 55
###begin p 56
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 991 992 991 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
###xml 38 44 <span type="species:ncbi:9606">humans</span>
###xml 132 137 <span type="species:ncbi:4932">yeast</span>
###xml 681 686 <span type="species:ncbi:4932">yeast</span>
Having confirmed that in yeast, as in humans, the H+ATPase and PFK are associated, we have gone on to demonstrate that the Pfk-null yeast vacuoles behave similarly to the G812R mutant strain, with much more severe impairment of proton transport than of ATPase activity, showing the necessity of this glycolytic enzyme for functional coupling of the different domains of the pump and supporting the concept that loss of function and uncoupling caused by the G812R substitution are directly associated with loss of binding of PFK-1 to a4C-GR. It is notable that whereas sufficient proton pump activity was present to permit rescue of the conditional growth phenotype in G812R mutant yeast, complete absence of Pfk did not permit growth under these conditions. This is consistent with previous studies demonstrating that a mutant strain with as little as 20% preservation of WT pump activity is sufficient to rescue the growth phenotype, whereas less than 20% of WT activity would display a Vma- phenotype (33, 37). In addition, complete absence of the glycolytic component may exert a greater overall metabolic derangement, for example an alternative carbon source to glucose must be provided to permit any growth at all.
###end p 56
###begin p 57
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 274 275 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r54">54</xref>
###xml 594 595 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 601 602 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 677 678 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 634 639 <span type="species:ncbi:4932">yeast</span>
Evidence supporting the involvement of glycolysis in regulation of H+ATPase function is not limited to our findings. Aldolase (the next enzyme down the glycolytic pathway) interacts with the H+ATPase via the E-subunit, but the mechanism is different, affecting assembly of V1 and V0 domains rather than their functional coupling (34, 36). Earlier assessment of proton transport in the isolated turtle urinary bladder showed that it could be driven by the energy from both aerobic and anaerobic glycolysis (2, 54). Also, investigation of the effect of glucose on the reversible assembly of the V1 and V0 domains of the pump complex in yeast suggested not only coupling between H+ATPase activity and glycolysis, but also that further glucose metabolism is required, since accumulation of glucose-6-phosphate was insufficient to maintain or induce pump assembly (46). Thus there are several means by which PFK-1 may function as an indirect regulator of the proton pump.
###end p 57
###begin p 58
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r60">60</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r57">57</xref>
###xml 829 830 829 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
During glycolysis, PFK-1 catalyzes the phosphorylation of F6P by MgATP to form fructose 1,6-bisphosphate and MgADP. Its activity is allosterically controlled by several activators and inhibitors (8). The active sites identified for substrate binding and allosteric regulation involve residues mainly located in the NH2-terminal half of PFK-1 (25, 26, 32, 60), whereas the binding region for the a-subunit that we identified is at the COOH-terminal end of PFK-1 (57). By comparison with the bacterial crystal structure, we could assume a priori that binding of a4 to PFK-1 would not affect its enzyme catalytic activities, and indeed, activity was not adversely affected by a4C. Thus we could exclude the possibility that abolishing the a4C/PFK-1 interaction exerts a direct effect on PFK-1 activity leading to secondary loss of H+ATPase function.
###end p 58
###begin p 59
###xml 339 348 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vph1&#916;</italic>
###xml 349 358 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stv1&#916;</italic>
###xml 438 440 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 599 600 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:4932">yeast</span>
Extrapolating between species does require some caution, and while we would have preferred to perform these studies in an epithelial system, no group has successfully established stable expression of mammalian a-subunits. In our studies, we utilized human constructs wherever possible, for example in the SPR and PFK enzymatic assays. The vph1Delta/stv1Delta mutant yeast strain is, however, a useful tool for the study of the a-subunit (39), as it can be rescued by restoration of either gene back into the double deletion strain, where it reassembles with the other subunits to reform functional H+ATPases. Thus transformation with WT or mutants of Vph1p alone, which normally resides in the vacuole, provides an effective cellular model.
###end p 59
###begin p 60
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 74 79 <span type="species:ncbi:4932">yeast</span>
###xml 462 467 <span type="species:ncbi:4932">yeast</span>
Our results for R807Q are in good agreement with the data obtained from a yeast mutagenesis study that employed different substitutions of this residue (24), in which changing the Arg to Leu, Ala, or Lys resulted in variable functional effects: dramatic destabilization of Vph1p, or a severe defect in assembly and activity of H+ATPase, or inactivated the pump without affecting assembly. In contrast, the earlier report of mutagenesis correlating to G820R in a yeast model noted above suggested a more severe decrement in ATPase activity than we observed, but similar compromise of proton translocation (44). Despite overall more severe functional compromise reported there, the mutant strains were still able to grow at alkaline pH in both studies. Possible reasons for the difference include methodological variations (for example, temperature, inhibitor, or buffer components) as well as the strain difference mentioned earlier. We ensured that the linear phase of enzyme activity was assessed at constant temperature, using reagents and equipment frequently in use and validated, and obtained similar and highly reproducible results in all assays.
###end p 60
###begin p 61
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
We were interested to consider the effects on vacuolar ATPase function of replenishing the PFK-null strain with a variant lacking the COOH-terminal domain that interacts with a4C. However, it has already been reported that such constructs result in only poor levels of protein expression, which would make interpretation impossible (9). Importantly, it has been previously demonstrated that the pump spontaneously disassembles when no glucose is present (21); thus for our assays, we were careful to include a small amount of glucose in the media in addition to the ethanol required by this null strain, to avoid confounding results.
###end p 61
###begin p 62
###xml 724 725 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 93 100 <span type="species:ncbi:9606">patient</span>
###xml 189 194 <span type="species:ncbi:9606">child</span>
Considering the phenotypic consequences of the two mutations in the patients themselves, the patient carrying two copies of the R807Q mutation has been much more severely affected than the child who is homozygous for G820R, with a younger age at diagnosis, more severe acidosis, and significant deafness. This difference is reflected in the differing effects of the mutations, since the R799Q mutation did not generate sufficient protein for any significant functional activity, whereas the G812R mutant was able to do so. Interestingly, despite its extremely low levels, almost all of the R799Q mutant produced appeared at the vacuolar membrane, implying this mutation per se does not affect assembly and targeting of the H+ATPase, but rather protein stability with an overall ablative effect on the pump. Thus this Arg residue is critical for stable expression of the a-subunit and therefore its function.
###end p 62
###begin p 63
###xml 704 705 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 777 778 777 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 1198 1206 1198 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP6V0A4</italic>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r56">56</xref>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 206 211 <span type="species:ncbi:9606">child</span>
###xml 346 353 <span type="species:ncbi:9606">patient</span>
###xml 697 702 <span type="species:ncbi:4932">yeast</span>
###xml 1113 1120 <span type="species:ncbi:9606">patient</span>
Hearing impairment is highly variable among those carrying destructive recessive mutations in a4, but the basis of the apparent redundancy of a4 function in the inner ear in some patients is not clear. The child with predicted complete loss of a4 function due to R807Q is severely hearing impaired, whereas hearing is at present preserved in the patient with the G820R change, who is now 17. In addition, her alkali requirement has progressively diminished as she has reached teenage. A formal dietary assessment has not been carried out to determine whether the difference can be accounted for by diet or by the milder course of her disease. Previous mutagenesis studies of different subunits of yeast H+ATPase demonstrate that growth can be observed if a reassembled mutant H+ATPase enzyme has as little as 20% of WT activity (33, 37), and since the milder mutant retained about this level of function in vitro, we can conclude that this level of activity is sufficient to maintain inner ear fluid pH homeostasis, but not to acidify the urine adequately, at least during childhood. In addition, this particular patient may yet lose hearing in young adulthood, in common with others with reported ATP6V0A4 mutation (56).
###end p 63
###begin p 64
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r57">57</xref>
In summary, these data demonstrate an important role for PFK-1 in normal proton pump function, that loss of a-subunit/PFK-1 interaction is likely to decrease the stability of the "metabolon" formed by various H+ATPase subunits (notably E and a) and glycolytic components (aldolase and PFK-1) (35, 57), and also that differing mechanisms for rdRTA underlie these point mutations in a4.
###end p 64
###begin title 65
GRANTS
###end title 65
###begin p 66
This study was funded by the Wellcome Trust. B. Javid was a Medical Research Council Training Fellow.
###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
[Supplemental Figures and Tables]
###end title 68
###begin p 69
###xml 77 82 <span type="species:ncbi:9606">Human</span>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
We thank W. Li, M. Eichner-Techau, E. Norgett (all CIMR), and J. Bason (Dunn Human Nutrition Unit) for technical assistance, and A. Nayir and J. Rodriguez-Soriano for referring patients 5-1 and 70-1.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin p 71
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 359 360 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
###xml 180 185 <span type="species:ncbi:4932">yeast</span>
###xml 319 324 <span type="species:ncbi:4932">yeast</span>
###xml 408 413 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:4932">yeast</span>
Confirmation of yeast H+ATPase/Pfk interaction and comparison of a-subunit COOH-terminal sequences. A: Co-IP of H+ATPase and Pfk from vacuoles of KEBY9 (a-subunit double deletion) yeast transformed with Vph1p. IP: (+) or (-) indicates inclusion or omission of alpha-Vma2p; IB: alpha-Pfk. A single band corresponding to yeast Pfk is seen in the (+) lane only. B: amino acid sequences of the COOH termini from human and yeast orthologs and paralogs are aligned. Residues at the start and end of this domain are numbered. The highly conserved first 17 amino acids are highlighted in gray. Conserved Arg (807 in a4 or 799 in Vph1p) and Gly (820 in a4 or 812 in Vph1p) residues are boxed.
###end p 71
###begin p 72
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VPH1-</italic>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VPH1-</italic>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VPH1</italic>
###xml 459 460 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 493 494 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 743 744 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 851 852 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 962 963 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 969 970 953 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1107 1110 1091 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 39 44 <span type="species:ncbi:4932">yeast</span>
###xml 114 119 <span type="species:ncbi:4932">yeast</span>
###xml 433 438 <span type="species:ncbi:4932">Yeast</span>
Effect of R799Q and G812R mutations on yeast growth, Vph1p expression, H+ATPase assembly, and targeting. A: KEBY9 yeast cells were transformed with relevant constructs containing one of either VPH1-R799Q (R>Q), VPH1-G812R (G>R), VPH1 (Vph1p), or empty vector. Images are of 30degreesC cultures. Functional complementation was observed from the G812R mutant at a level comparable to wild-type (WT) Vph1p, but not by the R799Q mutant. Yeast whole cell lysates (B) or vacuolar membrane vesicles (C) isolated from cells expressing WT or mutant forms of Vph1p, or control KEBY9 cells (Delta/Delta), were analyzed by Western blot using antibodies against Vph1p and/or Vma1p, densitometrically quantified, and expressed relative to WT (100%) +/- SE. B: whole cell lysate showed expression of both mutants, with G812R at WT levels and R799Q severely reduced. C: relative amounts of each mutant present on the vacuolar membranes mirrored that seen for whole cells. Both V0 and V1 subunits (Vph1p and Vma1p) were present in G812R and R799Q mutant vacuoles, indicating that each was capable of assembly and targeting (top).
###end p 72
###begin p 73
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VPH1</italic>
###xml 316 321 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 323 324 319 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 326 327 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 329 330 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 332 333 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 366 370 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left</italic>
###xml 393 394 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 419 420 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 433 434 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 474 479 470 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig 2</xref>
###xml 506 512 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 523 524 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 526 527 522 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 529 530 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 648 649 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 651 652 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
Indirect immunofluorescence examination of Vph1p expression and targeting. KEBY9 cells transformed with plasmid carrying either WT or mutant VPH1 were fixed, spheroplasted, and stained with polyclonal alpha-Vph1p antibody (green). To observe vacuoles, differential interference contrast (DIC) images were collected (right, C, F, I, L). DAPI-labeled nuclei are blue. Left: expression of R799Q (G) is much lower than WT (A) and G812R (D), consistent with Western blot data in Fig 2. At higher magnification (middle), images (B, E, H) confirm that both mutant proteins can reach the vacuolar membrane. Control KEBY9 cells (Delta/Delta) show no Vph1p (J, K). Scale bars = 3 mum.
###end p 73
###begin p 74
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 412 414 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 425 427 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 605 611 600 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
Effects of R799Q and G812R mutations on H+ATPase activity. Bafilomycin-sensitive ATPase activity and rate of ATP-dependent proton transport in vacuolar membrane vesicles isolated from cells expressing WT or mutant forms of Vph1p are shown as percentages of WT levels +/- SE. The specific activity of bafilomycin-sensitive ATPase activity of vacuoles containing WT-Vph1p was 1.02 +/- 0.09 mumol ATP hydrolyzed.min-1.mg protein-1. Approximately 70% of the ATPase activity of WT vacuoles was bafilomycin sensitive. Experiments were performed in triplicate in each of 2 preparations per strain. Supplementary Fig. 4 shows representative proton translocation traces.
###end p 74
###begin p 75
###xml 221 222 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 224 225 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 285 286 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 291 292 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 369 370 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 370 371 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 157 163 <span type="species:ncbi:9986">rabbit</span>
Surface plasmon resonance (SPR) assay of a4C/PFK-1 interaction. Synthetic human a4C peptides in the range 5-175 muM were analyzed for binding to immobilized rabbit PFK-1. Representative sensorgrams are displayed at left (A, C) and show amount of bound a4C-WT or a4C-GR (RU) over time. B and D: binding curves reveal saturable kinetics for the a4C-WT/PFK-1 interaction (Kd = 29.4 +/- 6.2 muM), whereas a4C-GR and PFK-1 interacted too weakly to permit calculation.
###end p 75
###begin p 76
###xml 179 184 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 259 266 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
Far-UV circular dichroism (CD) spectra of a4C-WT and a4C-GR. Each is the average of 10 spectra at 50 muM. Spectral shifts were the same for 25 muM peptides. The G820R spectrum is right-shifted compared with WT, suggesting a change in secondary structure. See Table 1 for structural modelling.
###end p 76
###begin p 77
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
PFK-1 activity assays. Enzyme activity was assayed with and without a4C-WT or a4C-GR. These peptides did not affect activity. Representative curves shown are means of triplicate replicates in 1 of 3 experiments. Curves fitted first-order kinetics (Origin software). See Table 2 for kinetic parameters.
###end p 77
###begin p 78
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFK</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 43 48 <span type="species:ncbi:4932">yeast</span>
###xml 239 244 <span type="species:ncbi:4932">yeast</span>
H+ATPase functional disruption in PFK-null yeast. Similar to the strain lacking H+ATPase a-subunits, acid-dependent growth is exhibited (A), and bafilomycin-sensitive ATPase activity and proton translocation rates are impaired in PFK-null yeast (B), confirming that Pfk is essential for normal proton pump function.
###end p 78
###begin p 79
Percentage of secondary structure elements present in a4 COOH-terminal 45 amino acids, estimated from 10 CD spectra using CDNN software
###end p 79
###begin p 80
WT, wild-type.
###end p 80
###begin p 81
Steady-state kinetic parameters for PFK-1 +/- WT or mutant a4C peptides
###end p 81
###begin p 82
Data are means +/- SE of 3 assays. No significant differences were found.
###end p 82

